» Articles » PMID: 35846989

Insights Into the Properties, Biological Functions, and Regulation of USP21

Overview
Journal Front Pharmacol
Date 2022 Jul 18
PMID 35846989
Authors
Affiliations
Soon will be listed here.
Abstract

Deubiquitylating enzymes (DUBs) antagonize ubiquitination by removing ubiquitin from their substrates. The role of DUBs in controlling various physiological and pathological processes has been extensively studied, and some members of DUBs have been identified as potential therapeutic targets in diseases ranging from tumors to neurodegeneration. Ubiquitin-specific protease 21 (USP21) is a member of the ubiquitin-specific protease family, the largest subfamily of DUBs. Although USP21 was discovered late and early research progress was slow, numerous studies in the last decade have gradually revealed the importance of USP21 in a wide variety of biological processes. In particular, the pro-carcinogenic effect of USP21 has been well elucidated in the last 2 years. In the present review, we provide a comprehensive overview of the current knowledge on USP21, including its properties, biological functions, pathophysiological roles, and cellular regulation. Limited pharmacological interventions for USP21 have also been introduced, highlighting the importance of developing novel and specific inhibitors targeting USP21.

Citing Articles

Unravelling the role of ubiquitin-specific proteases in breast carcinoma: insights into tumour progression and immune microenvironment modulation.

Yang H, Sun T, Sun Z, Wang H, Liu D, Wu D World J Surg Oncol. 2025; 23(1):60.

PMID: 39979972 PMC: 11841324. DOI: 10.1186/s12957-025-03667-8.


Chemical approaches to explore ubiquitin-like proteins.

Mousa R, Shkolnik D, Alalouf Y, Brik A RSC Chem Biol. 2025; .

PMID: 39950163 PMC: 11817102. DOI: 10.1039/d4cb00220b.


METTL3-Mediated m6A Methylation of USP21 Contributes to Hepatocellular Carcinoma Progression by Stabilizing H2BFS Through Deubiquitination.

Yao P, Li X, Chai J, Dong J, Chen Y, Zhang T Biochem Genet. 2024; .

PMID: 39680331 DOI: 10.1007/s10528-024-10992-2.


Roles of deubiquitinases in urologic cancers (Review).

Wu L, Wang J, Chai L, Chen J, Jin X Oncol Lett. 2024; 28(6):609.

PMID: 39525605 PMC: 11544529. DOI: 10.3892/ol.2024.14743.


The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma.

Zeng L, Li Y, He S, Xu H, Zhang R, Chen K Neuro Oncol. 2024; 27(2):492-507.

PMID: 39215663 PMC: 11812030. DOI: 10.1093/neuonc/noae175.


References
1.
Fatma H, Siddique H, Maurya S . The multiple faces of NANOG in cancer: a therapeutic target to chemosensitize therapy-resistant cancers. Epigenomics. 2021; 13(23):1885-1900. DOI: 10.2217/epi-2021-0228. View

2.
Li Y, Yuan J . Role of deubiquitinating enzymes in DNA double-strand break repair. J Zhejiang Univ Sci B. 2021; 22(1):63-72. PMC: 7818009. DOI: 10.1631/jzus.B2000309. View

3.
Guo Q, Shi D, Lin L, Li H, Wei Y, Li B . De-Ubiquitinating Enzymes USP21 Regulate MAPK1 Expression by Binding to Transcription Factor GATA3 to Regulate Tumor Growth and Cell Stemness of Gastric Cancer. Front Cell Dev Biol. 2021; 9:641981. PMC: 8005622. DOI: 10.3389/fcell.2021.641981. View

4.
Tao L, Chen C, Song H, Piccioni M, Shi G, Li B . Deubiquitination and stabilization of IL-33 by USP21. Int J Clin Exp Pathol. 2014; 7(8):4930-7. PMC: 4152054. View

5.
Smith T, Southan C . Sequencing, tissue distribution and chromosomal assignment of a novel ubiquitin-specific protease USP23. Biochim Biophys Acta. 2000; 1490(1-2):184-8. DOI: 10.1016/s0167-4781(99)00233-x. View